CrossrefInfokarte
Familial TLR8 gain-of-function presenting as HLH with response to IFN-γ blockade
Journal of Human Immunity · 2027-01-04 · 3 (1)
DOI: 10.70962/jhi.20260101 ↗Abstract
Gain-of-function variants in TLR8 cause X-linked immune dysregulation characterized by cytopenias, bone marrow failure, and lymphoproliferation. We report an 8-year-old male in whom TLR8-GOF manifested as hemophagocytic lymphohistiocytosis, an association not previously described. Treatment with emapalumab was associated with clinical improvement.
EUVIMED